Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2010 Feb 1;120(2):645. doi: 10.1172/JCI39845C1

Latent TGF-β–binding protein 4 modifies muscular dystrophy in mice

Ahlke Heydemann, Ermelinda Ceco, Jackie E Lim, Michele Hadhazy, Pearl Ryder, Jennifer L Moran, David R Beier, Abraham A Palmer, Elizabeth M McNally
PMCID: PMC2810081

Original citation: J. Clin. Invest. 2009;119(12):3703–3712. doi:10.1172/JCI39845.

Citation for this corrigendum: J. Clin. Invest. 2010;120(2):645. doi:10.1172/JCI39845C1.

During the preparation of this manuscript, Abraham A. Palmer's affiliation was given incorrectly. The correct affiliation appears below.

Department of Human Genetics, University of Chicago, Chicago, Illinois, USA.

During the preparation of this manuscript, reference 12 was inadvertently presented incorrectly. The incorrect reference is on page 3712. The correct reference appears below.

Department of Human Genetics, University of Chicago, Chicago, Illinois, USA.

12. Cohn, R.D., et al. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat. Med. 13:204–210.

The authors regret the errors.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES